NCT02318706View on ClinicalTrials.gov

DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

854

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 29, 2017

Study Completion Date

June 29, 2017

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

DS-5565

DRUG

placebo

Trial Locations (1)

876-0851

Saiki Central Hospital, Ōita

Sponsors
All Listed Sponsors
collaborator

CMIC Co, Ltd. Japan

INDUSTRY

collaborator

Quintiles, Inc.

INDUSTRY

collaborator

Quintiles Malaysia Sdn Bhd

INDUSTRY

lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT02318706 - DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter